73 related articles for article (PubMed ID: 2790805)
1. Enhancing effect of human monocytic colony-stimulating factor on monocyte tumoricidal activity.
Suzu S; Yokota H; Yamada M; Yanai N; Saito M; Kawashima T; Saito M; Takaku F; Motoyoshi K
Cancer Res; 1989 Nov; 49(21):5913-7. PubMed ID: 2790805
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of human monocyte tumoricidal activity by recombinant M-CSF.
Sampson-Johannes A; Carlino JA
J Immunol; 1988 Nov; 141(10):3680-6. PubMed ID: 3053901
[TBL] [Abstract][Full Text] [Related]
3. [Human monocytic colony-stimulating factor].
Motoyoshi K
Gan To Kagaku Ryoho; 1989 Nov; 16(11):3531-6. PubMed ID: 2684018
[TBL] [Abstract][Full Text] [Related]
4. Effect of recombinant granulocyte/macrophage colony-stimulating factor on human monocyte activity in vitro and following intravenous administration.
Kleinerman ES; Knowles RD; Lachman LB; Gutterman JU
Cancer Res; 1988 May; 48(9):2604-9. PubMed ID: 3128401
[TBL] [Abstract][Full Text] [Related]
5. Effect of cisplatin treatment of human monocyte cell line U937 on the induction of tumoricidal activity.
Singh RK; Singh SM; Sodhi A
Neoplasma; 1992; 39(3):137-40. PubMed ID: 1528316
[TBL] [Abstract][Full Text] [Related]
6. Macrophage growth factor CSF-1 stimulates human monocyte production of interferon, tumor necrosis factor, and colony stimulating activity.
Warren MK; Ralph P
J Immunol; 1986 Oct; 137(7):2281-5. PubMed ID: 2428865
[TBL] [Abstract][Full Text] [Related]
7. Mode of action of human urinary colony-stimulating factor.
Ishizaka Y; Motoyoshi K; Hatake K; Saito M; Takaku F; Miura Y
Exp Hematol; 1986 Jan; 14(1):1-8. PubMed ID: 3484706
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of the antibody-dependent tumoricidal activity of human monocytes by human monocytic colony-stimulating factor.
Suzu S; Yanai N; Saito M; Kawashima T; Kasahara T; Saito M; Takaku F; Motoyoshi K
Jpn J Cancer Res; 1990 Jan; 81(1):79-84. PubMed ID: 2108950
[TBL] [Abstract][Full Text] [Related]
9. Recombinant granulocyte-macrophage colony-stimulating factor down-regulates expression of IL-2 receptor on human mononuclear phagocytes by induction of prostaglandin E.
Hancock WW; Pleau ME; Kobzik L
J Immunol; 1988 May; 140(9):3021-5. PubMed ID: 3129507
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of monocytosis and human monocytic colony-stimulating factor in patients with adult T-cell leukaemia/lymphoma.
Tokioka T; Shimamoto Y; Motoyoshi K; Yamaguchi M
Haematologia (Budap); 1994; 26(1):1-9. PubMed ID: 7959369
[TBL] [Abstract][Full Text] [Related]
11. Involvement of tumor necrosis factor in cytotoxicity mediated by human monocytes.
Nissen-Meyer J; Hofsli E; Espevik T; Austgulen R
Nat Immun Cell Growth Regul; 1988; 7(5-6):266-79. PubMed ID: 3146697
[TBL] [Abstract][Full Text] [Related]
12. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
[TBL] [Abstract][Full Text] [Related]
13. Serum colony stimulating factors in patients undergoing bone marrow transplantation: enhancing effect of recombinant human GM-CSF.
Geissler D; Niederwieser D; Aulitzky WE; Tilg H; Grünewald K; Huber C; Konwalinka G
Behring Inst Mitt; 1988 Aug; (83):289-300. PubMed ID: 3071343
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor as effector molecule in monocyte mediated cytotoxicity.
Ziegler-Heitbrock HW; Möller A; Linke RP; Haas JG; Rieber EP; Riethmüller G
Cancer Res; 1986 Nov; 46(11):5947-52. PubMed ID: 3756932
[TBL] [Abstract][Full Text] [Related]
15. Role of interleukin 1 in promoting human monocyte-mediated tumor cytotoxicity.
Onozaki K; Matsushima K; Kleinerman ES; Saito T; Oppenheim JJ
J Immunol; 1985 Jul; 135(1):314-20. PubMed ID: 3873493
[TBL] [Abstract][Full Text] [Related]
16. Induction of tumour necrosis factor receptor-expressing macrophages by interleukin-10 and macrophage colony-stimulating factor in rheumatoid arthritis.
Takasugi K; Yamamura M; Iwahashi M; Otsuka F; Yamana J; Sunahori K; Kawashima M; Yamada M; Makino H
Arthritis Res Ther; 2006; 8(4):R126. PubMed ID: 16859503
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte-macrophage colony-stimulating factor, but not macrophage colony-stimulating factor, suppresses basal and lipopolysaccharide-stimulated complement factor production in human monocytes.
Høgåsen AK; Hestdal K; Abrahamsen TG
J Immunol; 1993 Sep; 151(6):3215-24. PubMed ID: 7690797
[TBL] [Abstract][Full Text] [Related]
18. Constitutive production and release of a lymphokine with macrophage-activating factor activity distinct from gamma-interferon by a human T-cell leukemia virus-positive cell line.
Kleinerman ES; Zicht R; Sarin PS; Gallo RC; Fidler IJ
Cancer Res; 1984 Oct; 44(10):4470-5. PubMed ID: 6088039
[TBL] [Abstract][Full Text] [Related]
19. Colony-stimulating factor-induced monocyte survival and differentiation into macrophages in serum-free cultures.
Becker S; Warren MK; Haskill S
J Immunol; 1987 Dec; 139(11):3703-9. PubMed ID: 2824612
[TBL] [Abstract][Full Text] [Related]
20. Induction of surface tumor necrosis factor (TNF) expression and possible facilitation of surface TNF release from human monocytic cells by granulocyte-macrophage colony-stimulating factor or gamma interferon in combination with 1,25-dihydroxyvitamin D3.
Kelsey SM; Allen PD; Razak K; Macey MG; Newland AC
Exp Hematol; 1993 Jul; 21(7):864-9. PubMed ID: 8319779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
